Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing

BSX

Boston Scientific Corp

Last Close
44.10
Nov 09 • 12:19 PM ET Dollar change+1.35 Percentage change(3.15%)
Overview Compare Short Interest Financials Options Filings Dilution
Healthcare Medical Devices USA Large NYSE
Nov 06, 5:35 PMS&P Global cuts Boston Scientific outlook to negative, affirms ‘A-’ rating on leverage and franchise pressures
Peers: MDT ABT EW SYK PEN BDX JNJ ATRC ISRG TFX
 | Held by: VTI VOO IVV SPY VO VTV XLV RSP VHT VOE
Scroll to Statements
Index
S&P 500
Market Cap
63.91B
Enterprise Value
75.44B
Income
3.50B
Sales
21.07B
Book/sh
17.68
Cash/sh
0.46
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
59000
IPO
May 19, 1992
P/E
18.67
Forward P/E
14.09
PEG
4.36
P/S
3.03
P/B
2.49
P/C
95.82
P/FCF
19.19
EV/EBITDA
12.68
EV/Sales
3.58
Quick Ratio
0.81
Current Ratio
1.36
Debt/Eq
0.47
LT Debt/Eq
0.43
Option/Short
Yes / Yes
EPS (ttm)
2.36
EPS next Y
3.13
EPS next Q
0.78
EPS this Y
3.36%
EPS next Y
-1.06%
EPS next 5Y
3.23%
EPS past 3/5Y
63.23% -
Sales past 3/5Y
16.54% 15.16%
EPS Y/Y TTM
25.77%
Sales Y/Y TTM
8.88%
EPS Q/Q
-20.60%
Sales Q/Q
1.44%
Earnings
Oct 28 BMO
EPS/Sales Surpr.
0.43% 0.99%
Insider Own
0.65%
Insider Trans
2.24%
Inst Own
94.97%
Inst Trans
0.42%
ROA
7.94%
ROE
14.29%
ROIC
9.58%
Gross Margin
65.59%
Oper. Margin
21.44%
Profit Margin
16.62%
SMA20
-0.30%
SMA50
-0.41%
SMA200
-20.00%
Trades
Shs Outstand
1.45B
Shs Float
1.44B
Short Float
2.83%
Short Ratio
2.05
Short Interest
40.71M
52W High
105.65 -58.26%
52W Low
39.57 11.44%
Volatility
4.60% 3.54%
ATR (14)
1.77
RSI (14)
49.88
Beta
0.57
Rel Volume
0.71
Avg Volume
19.81M
Volume
6,492,149
Perf Week
-0.51%
Perf Month
3.19%
Perf Quarter
-13.86%
Perf Half Y
-17.38%
Perf YTD
-53.75%
Perf Year
-55.91%
Perf 3Y
-14.26%
Perf 5Y
3.05%
Perf 10Y
101.90%
Recom
1.75
Target Price
50.07
Prev Close
42.75
Price
44.10
Change %
3.15%
Consensus
Buy
Avg. Price Target
$50.07
Implied Upside
+13.6%
Analysts18incl. previous ratings
Rating Distribution9 Buy · 9 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 30, 2026Downgrade
TD logoTTD Cowen
Buy → Hold$46+4.3%
Oct 29, 2026Downgrade
OPY logoOOppenheimer
Outperform → Perform
Oct 28, 2026Downgrade
JPM logoJJP Morgan
Overweight → Neutral$46+4.3%
Oct 07, 2026Initiated
BCS logoBBarclays
Equal Weight$48+8.9%
Sep 17, 2026Downgrade
C logoCCitigroup
Buy → Neutral$50+13.4%
Jul 31, 2026Downgrade
AArgus
Buy → Hold
May 29, 2026Downgrade
WWolfe Research
Outperform → Peer Perform
May 28, 2026Downgrade
WFC logoWWells Fargo
Overweight → Equal Weight$55+24.7%
Mar 30, 2026Downgrade
RJF logoRRaymond James
Strong Buy → Outperform$88+99.6%
Oct 03, 2025Downgrade
EErste Group
Buy → Hold
Show Previous News
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Sullivan MiriamSVP, Chief HR OfficerNov 01 '26Option Exercise0.003,871021,437Nov 03 06:14 PM
O'Connor Padraig AndrewEVP, Global OperationsSep 02 '26Option Exercise0.001,17108,459Sep 03 04:34 PM
Morano Susan EDirectorAug 25 '26Buy49.222,040100,40813,784Aug 26 06:46 PM
Habiger David CDirectorAug 05 '26Buy47.592,10099,93717,160Aug 07 04:16 PM
Habiger David CDirectorAug 03 '26Buy48.071,04250,08414,920Aug 05 04:15 PM
Habiger David CDirectorAug 04 '26Buy48.591406,80215,060Aug 05 04:15 PM
Mahoney Michael FChairman, President & CEOAug 03 '26Buy48.33186,2409,001,4081,590,024Aug 05 04:15 PM
LUDWIG EDWARD JDirectorJul 31 '26Buy45.485,000227,40030,359Aug 03 04:29 PM
Monson JonathanEVP and CFOJul 01 '26Option Exercise0.002,087040,073Jul 02 04:07 PM
Pegus CherylDirectorMay 20 '26Buy56.491,77099,9871,770May 21 05:21 PM
LUDWIG EDWARD JDirectorMay 20 '26Buy56.683,580202,91425,359May 21 05:21 PM
Habiger David CDirectorMay 20 '26Buy55.922,250125,81913,878May 21 05:20 PM
Habiger David CDirectorMay 19 '26Buy56.952,200125,27911,628May 21 05:20 PM
O'Connor Padraig AndrewEVP, Global OperationsMay 02 '26Option Exercise0.001,80207,896May 04 05:30 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACMay 02 '26Option Exercise0.002,102057,894May 04 05:30 PM
Woodworth EmilySVP, Global Controller and CAOMar 01 '26Option Exercise0.0083803,231Mar 03 05:19 PM
O'Connor Padraig AndrewEVP, Global OperationsFeb 16 '26Option Exercise0.0090506,433Feb 18 05:58 PM
O'Connor Padraig AndrewEVP, Global OperationsFeb 14 '26Option Exercise0.001,19005,977Feb 18 05:58 PM
O'Connor Padraig AndrewEVP, Global OperationsFeb 13 '26Option Exercise0.0050004,986Feb 18 05:58 PM
Woodworth EmilySVP, Global Controller and CAOFeb 16 '26Option Exercise0.0063702,676Feb 18 05:58 PM
Woodworth EmilySVP, Global Controller and CAOFeb 14 '26Option Exercise0.0066102,335Feb 18 05:58 PM
Woodworth EmilySVP, Global Controller and CAOFeb 13 '26Option Exercise0.001,41302,364Feb 18 05:58 PM
Monson JonathanEVP and CFOFeb 16 '26Option Exercise0.00990038,426Feb 18 05:58 PM
Monson JonathanEVP and CFOFeb 14 '26Option Exercise0.001,058037,906Feb 18 05:58 PM
Monson JonathanEVP and CFOFeb 13 '26Option Exercise0.001,766037,636Feb 18 05:58 PM
O'Sullivan MiriamSVP, Chief HR OfficerFeb 16 '26Option Exercise0.00990017,593Feb 18 05:58 PM
O'Sullivan MiriamSVP, Chief HR OfficerFeb 14 '26Option Exercise0.001,124016,932Feb 18 05:58 PM
O'Sullivan MiriamSVP, Chief HR OfficerFeb 13 '26Option Exercise0.00588016,008Feb 18 05:58 PM
Mahoney Michael FChairman, President & CEOFeb 16 '26Option Exercise0.0016,26501,584,725Feb 18 05:58 PM
Mahoney Michael FChairman, President & CEOFeb 14 '26Option Exercise0.0016,52401,576,450Feb 18 05:58 PM
Mahoney Michael FChairman, President & CEOFeb 13 '26Option Exercise0.008,83201,692,025Feb 18 05:58 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 16 '26Option Exercise0.003,9600215,713Feb 18 05:58 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 14 '26Option Exercise0.004,3620213,743Feb 18 05:58 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 13 '26Option Exercise0.002,7970242,485Feb 18 05:58 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 16 '26Option Exercise0.002,546057,021Feb 18 05:57 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 14 '26Option Exercise0.003,173056,010Feb 18 05:57 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 13 '26Option Exercise0.002,237077,987Feb 18 05:57 PM
Brown Vance REVP, GC and Corp. SecretaryFeb 16 '26Option Exercise0.001,839055,134Feb 18 05:57 PM
Brown Vance REVP, GC and Corp. SecretaryFeb 14 '26Option Exercise0.001,851054,190Feb 18 05:57 PM
Brown Vance REVP, GC and Corp. SecretaryFeb 13 '26Option Exercise0.001,118065,131Feb 18 05:57 PM
O'Sullivan MiriamSVP, Chief HR OfficerFeb 12 '26Option Exercise0.00961015,758Feb 17 07:09 PM
Woodworth EmilySVP, Global Controller and CAOFeb 12 '26Option Exercise0.0048101,193Feb 17 07:07 PM
O'Connor Padraig AndrewEVP, Global OperationsFeb 12 '26Option Exercise0.001,05804,943Feb 17 07:07 PM
Monson JonathanEVP and CFOFeb 12 '26Option Exercise0.001,154036,443Feb 17 07:06 PM
Mahoney Michael FChairman, President & CEOFeb 12 '26Option Exercise0.0013,70401,425,439Feb 17 07:06 PM
Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyFeb 12 '26Option Exercise0.003,4620171,504Feb 17 07:06 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACFeb 12 '26Option Exercise0.002,692026,292Feb 17 07:05 PM
Brown Vance REVP, GC and Corp. SecretaryFeb 12 '26Option Exercise0.001,442034,893Feb 17 07:05 PM
Mahoney Michael FChairman, President & CEOFeb 02 '26Option Exercise25.7895,7542,468,4821,572,636Feb 03 04:12 PM
Mahoney Michael FChairman, President & CEOFeb 02 '26Sale93.49160,90115,043,3941,411,735Feb 03 04:12 PM
MICHAEL F MAHONEYOfficerFeb 02 '26Proposed Sale93.49160,90115,043,390Feb 02 04:12 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACDec 01 '25Option Exercise24.8117,313429,49140,913Dec 02 05:04 PM
Butcher Arthur CEVP& Grp Pres, MedSurg & APACDec 01 '25Sale101.5517,3131,758,18923,600Dec 02 05:04 PM
ARTHUR C BUTCHEROfficerDec 01 '25Proposed Sale101.5517,3131,758,188Dec 01 04:02 PM
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
ChairmanMr. Michael F. Mahoney
Executive VP & CFOMr. Jonathan R. Monson
EVPMr. Vance R. Brown J.D.
Executive VP & Group President of CardiovascularMr. Joseph M. Fitzgerald
Executive VP and Group President of MedSurg & Asia PacificMr. Arthur Crosswell Butcher
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)